News from

Perelman School of Medicine

Visit the School's Site
Reset All Filters
2723 Results
Proton therapy lowers risk of side effects in cancer patients
The particle accelerator, which sends protons down a beamline as long as a football field through three-story-high gantries, delivers the most cutting-edge proton therapy there is.

Proton therapy lowers risk of side effects in cancer patients

Proton therapy leads to a significantly lower risk of side effects severe enough to lead to unplanned hospitalizations for cancer patients when compared with traditional radiation. Cure rates between the two groups are almost identical.

Penn Today Staff

A gift for disruption: Visionary Roderick Wong gives back to PennHealthX
Amy Gutmann watches as Roderick Wong signs his gift to the Perelman School of Medicine.

Penn President Amy Gutmann and Roderick Wong at the signing ceremony for Wong’s gift to fund PennHealthX.

A gift for disruption: Visionary Roderick Wong gives back to PennHealthX

Wong, an alum with a medical degree and an MBA, has given Penn Medicine a $6 million gift to endow the Roderick T. Wong PennHealthX Program, one of the largest single gifts to support medical education.

Penn Today Staff

A new era in cystic fibrosis treatment
illustration of lungs as a symbol of cystic fibrosis research

A new era in cystic fibrosis treatment

FDA approval of new therapies for cystic fibrosis is a major breakthrough for patients, meaning fewer complications, delayed progression and even longer life expectancies.

Penn Today Staff

Using radiomics to predict breast cancer
nurse in surgery outfit is holding a mammogram in front of x-ray illuminator

Using radiomics to predict breast cancer

Penn researchers can predict 10-year breast cancer recurrence with MRI scans that characterize the genetic makeup of tumors, allowing for individualized, non-invasive treatment.

Penn Today Staff

Promising findings for multiple myeloma immunotherapy
Lab technician with a sample of plasma blood analyzing the results

Promising findings for multiple myeloma immunotherapy

Adam Cohen of the Perelman School of Medicine headed a clinical trial that found an experimental therapy can make a difference for patients who have exhausted other options.

Penn Today Staff

Engineering the immune system to tackle glioblastoma
x-ray of a brain tumor

Engineering the immune system to tackle glioblastoma

Immunotherapy is a “game changer” for improving outcomes in treating Glioblastoma Multiforme, the most common, and most lethal, malignant brain tumor in adults.

Penn Today Staff

Side Gigs for Good, part three
Two people sitting on an L-shaped couch amidst four pillows. The one on the right is holding a clipboard.

Altagracia Felix (right) is a financial coordinator for the Annenberg School for Communication, but she also has a side gig as a money coach. Her aim is to help “disrupt the cycle of poverty and struggle,” she says. (Image: Courtesy of Altagracia Felix)

Side Gigs for Good, part three

The final 2019 installment in our series highlighting impactful work Penn faculty and staff do.

Katherine Unger Baillie , Michele W. Berger

Side Gigs for Good, part two
Person walks a black Labrador retriever puppy along a path from a parking lot

Heather Calvert, executive director of MindCORE, drops off her foster puppy Ugo at the School of Veterinary Medicine's Working Dog Center at Pennovation Works each weekday. She and her family care for the working-dog-in-training during evenings, weekends, and holidays. 

Side Gigs for Good, part two

In a second installment of Side Gigs for Good stories, meet four more Penn employees whose after-work endeavors go above and beyond.

Katherine Unger Baillie , Michele W. Berger